Safety and reactogenicity of a novel DTPa-HBV-IPV combined vaccine given along with commercial Hib vaccines in comparison with separate concomitant administration of DTPa, Hib, and OPV vaccines in infants.

Source:http://linkedlifedata.com/resource/pubmed/id/11927731

Download in:

View as

General Info

PMID
11927731